https://doi.org/10.1093/annonc/mdy096
A
Akmal Safwat
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
130
Papers
8.4K
Citations
31
h-index
76
i10-index
Akmal Safwat is an academic researcher from Aarhus University. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Effects of Radiation Exposure & Vascular Tumors and Angiosarcomas. The author has an h-index of 31, co-authored 111 publications.
ORCID: 0000-0002-6020-2320Papers by this author
worksSoft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 · Annals of Oncology · 1,598 citations
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 · Annals of Oncology · 623 citations
https://doi.org/10.1093/annonc/mdy310
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
2021 · Annals of Oncology · 524 citations
https://doi.org/10.1016/j.annonc.2021.09.005
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
2016 · The Lancet Oncology · 517 citations
https://doi.org/10.1016/s1470-2045(16)30214-5
Corrections to “Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up”
2018 · Annals of Oncology · 186 citations
https://doi.org/10.1093/annonc/mdy320
European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN
2021 · ESMO Open · 33 citations
https://doi.org/10.1016/j.esmoop.2021.100174
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat